Physician profile
Michael J Sumko
NPI 1992937189
$25,527.29
in general payments reported to CMS, 2019-2025
26 companies · $1,403 in 2025
The $1,403 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.48 · 2020: $547 · 2021: $21K · 2022: $802 · 2023: $564 · 2024: $793 · 2025: $1,403.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,759.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,759.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exactech, INC. | $20,236.91 | 2021 | |
| Stryker Corporation | $3,459.49 | 2020-2025 | Mako, Triathlon, Motionsense Digital Goniometer |
| Smith+Nephew, INC. | $340.48 | 2020-2025 | Legion |
| Pacira Therapeutics, INC. | $166.89 | 2020-2021 | |
| Depuy Synthes Sales INC. | $148.21 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $147.05 | 2021-2025 | Iovera, Zilretta |
| Medtronic, INC. | $146.46 | 2025 | Inceptiv |
| Next Science LLC | $139.75 | 2024 | Xperience, Blastx, Surgx |
| Ferring Pharmaceuticals INC. | $130.62 | 2021-2024 | Euflexxa |
| Abbott Laboratories | $82.79 | 2024 | Eterna |
| Ethicon US, LLC | $65.80 | 2020-2022 | |
| Globus Medical, INC. | $65.30 | 2025 | Senza |
| Sanofi-Aventis U.S. LLC | $56.06 | 2019-2020 | |
| Zyla Life Sciences, INC. | $55.24 | 2020 | |
| Aap Implants INC | $43.38 | 2021-2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $36.61 | 2022 | |
| Nextstep Arthropedix, LLC | $33.66 | 2023 | Insitu Hip System |
| Orthogenrx INC. | $32.06 | 2019 | |
| Bioventus LLC | $26.88 | 2021 | |
| Hologic Sales and Service, LLC | $24.88 | 2023 | Myosure Tissue Removal Device, Omni Hysteroscope, Novasure |
| Orthofix Medical, INC. | $22.09 | 2020 | |
| Heraeus Medical, LLC. | $14.33 | 2020 | |
| Integra Lifesciences Corporation | $14.30 | 2019 | |
| Nalu Medical, INC. | $12.97 | 2021 | |
| Avanos Medical | $12.87 | 2021 | |
| Nevro Corp. | $12.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Sumko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.